Attila Teoman
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Ovarian cancer diagnosis and treatment, Cancer, Hypoxia, and Metabolism, Fibroblast Growth Factor Research, Genomics and Chromatin Dynamics
Most-Cited Works
- → Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer(2013)537 cited
- → Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas(2012)195 cited
- → PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples(2015)63 cited
- → Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk(2014)36 cited
- → CX3CL1 Overexpression Prevents the Formation of Lung Metastases in Trastuzumab-Treated MDA-MB-453-Based Humanized Tumor Mice (HTM)(2021)12 cited
- → Abstract 3695: The utility of plasma vascular endothelial growth factor and heparanase as pharmacodynamic markers following treatment with PG545, a heparan sulfate mimetic: preliminary evidence from preclinical and clinical settings(2014)
- → Is chronic prostatitis associated with chronic rhinosinusitis? A study based on “NIH-CPSI” and “SNOT-22” questionnaires(2019)
- → Abstract LB-309: The heparan sulfate mimetic PG545 increases plasma VEGF and FGF-2 in advanced cancer patients, and significantly inhibits tumor growth in preclinical models of ovarian cancer - implications for future therapy(2012)